Breaking News Headlines Today

News from Endovascular Today

All of today’s top news stories from Endovascular Today. Get the full analysis behind how media bias impacts breaking news.

In total, 39 have been published by Endovascular Today which Ground News has aggregated in the past 3 months.

Endovascular Today’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Endovascular Today

Where is Endovascular Today located?Endovascular Today's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Diabetic Foot and Venous Leg Ulcers Treated With BioLab’s Amnion-Based Products to Be Studied in BIOCAMP - Endovascular Today

August 12, 2025—BioLab Holdings, Inc., recently announced the initiation of the BIOCAMP study assessing the company’s human placental membrane (HPM) products in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The minimally manipulated allografts are derived from human amniotic membrane and designed to preserve the tissue’s natural properties and support healing, stated the company. According to BioLab, the …Read Article

Merit Launches Prelude Wave Hydrophilic Sheath Introducer With SnapFix Technology - Endovascular Today

August 12, 2025—Merit Medical Systems, Inc. recently announced the United States commercial release of the Prelude Wave hydrophilic sheath introducer with SnapFix securement technology. Merit noted that the Prelude Wave is part of the company’s Access portfolio, which includes a range of dilators, microaccess systems, sheath introducers, and guide sheaths. According to the company, the low-profile Prelude Wave with SnapFix technology is designed…Maryland · Maryland Read Article

Instylla Appoints Sean Boyle as Chief Executive Officer - Endovascular Today

August 5, 2025—Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced the appointment of Sean Boyle as Chief Executive Officer. Boyle will replace Amar Sawhney as CEO. Sawhney will continue as Chairman of the Board of the company. According to the company, Boyle brings 15 years of leadership in the medical device industry with experience in diverse business units. Before joini…United States · United States Read Article

SIO’s ACCLAIM Trial Completes Enrollment - Endovascular Today

August 5, 2025—The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ACCLAIM—Ablation With Confirmation of Colorectal Liver Metastases. This milestone was achieved 8 months ahead of schedule, noted SIO. According to the society, the ACCLAIM trial enrolled 240 patients (330 tumors) diagnosed with colorectal cancer liver metastases. The study was conducted in collaboration with nine le…Maryland · Maryland Read Article

CANSCAN Trial of AVF Mapping With VxWave Ultrasound Imaging System Completes Enrollment - Endovascular Today

July 29, 2025—Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility study evaluating the use of semiautonomous ultrasound scanning with Vexev’s VxWave system for arteriovenous fistula (AVF) mapping in dialysis clinics. Vexev is an Australian-based medical device company focused on vascular imaging, and U.S. Renal Care is a United States provider of in-center and home dialysis. T…Maryland · Maryland See the Story

Inari Medical, Now Part of Stryker, Launches InThrill Thrombectomy System - Interventional News

100% Center coverage: 4 sources

InThrill thrombectomy system Inari Medical—now part of Stryker—has today announced the launch of its next-generation InThrill thrombectomy system. The company has stated in a recent press release that this is the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal. The second generation InThrill thrombectomy system is an 8Fr over-the-wire system comprising t…Portage, Michigan · Portage See the Story

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

100% Center coverage: 1 sources

LATHAM, N.Y.--(BUSINESS WIRE)--Jul 28, 2025-See the Story

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

75% Left coverage: 4 sources

July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands –...United States · United States See the Story

Imperative Care Secures FDA Clearance and Initial Cases of the Zoom 7X Catheter, the Newest Innovation in Ischemic Stroke Treatment

100% Center coverage: 1 sources

CAMPBELL, Calif.--(BUSINESS WIRE)--Jul 23, 2025-Campbell, California · Campbell See the Story

News from Endovascular Today

News from Endovascular Today

Information about Endovascular Today

Media Bias Ratings

Factuality

Ownership

Top Endovascular Today News

HistoSonics Valued at $2B+ in Deal with Investors Including K5, Bezos

FDA Approves PEG Hydrogel Embolic System for Hypervascular Tumors

Diabetic Foot and Venous Leg Ulcers Treated With BioLab’s Amnion-Based Products to Be Studied in BIOCAMP - Endovascular Today

Merit Launches Prelude Wave Hydrophilic Sheath Introducer With SnapFix Technology - Endovascular Today

Instylla Appoints Sean Boyle as Chief Executive Officer - Endovascular Today

SIO’s ACCLAIM Trial Completes Enrollment - Endovascular Today

CANSCAN Trial of AVF Mapping With VxWave Ultrasound Imaging System Completes Enrollment - Endovascular Today

Inari Medical, Now Part of Stryker, Launches InThrill Thrombectomy System - Interventional News

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Imperative Care Secures FDA Clearance and Initial Cases of the Zoom 7X Catheter, the Newest Innovation in Ischemic Stroke Treatment

Similar News Topics

Topics Most Covered by Endovascular Today

Sources Covering Similar Topics

Breaking News Topics Related to Endovascular Today

Information about Endovascular Today

Media Bias Ratings

Factuality

Ownership

Merit Launches Prelude Wave Hydrophilic Sheath Introducer With SnapFix Technology - Endovascular Today

Instylla Appoints Sean Boyle as Chief Executive Officer - Endovascular Today

SIO’s ACCLAIM Trial Completes Enrollment - Endovascular Today

CANSCAN Trial of AVF Mapping With VxWave Ultrasound Imaging System Completes Enrollment - Endovascular Today

Inari Medical, Now Part of Stryker, Launches InThrill Thrombectomy System - Interventional News

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Imperative Care Secures FDA Clearance and Initial Cases of the Zoom 7X Catheter, the Newest Innovation in Ischemic Stroke Treatment